Codiak BioSciences

for sale close down for sale sign business
Biotech

Codiak Biosciences files for bankruptcy

Another biotech bites the dust. This time it’s Codiak Biosciences, whose attempts to deliver exosome-based therapeutics have come to an end.
James Waldron Mar 27, 2023 10:42am
illustration of an employee picking a layoff letter from an envelope

Codiak trims down team and pipeline despite $2.5M boost in July

Aug 30, 2022 11:30am
cell mutation

Codiak gets $2.5M from CEPI to forge way out of pandemic

Jul 5, 2022 3:36pm
Wall Street sign

2nd time's the charm for Codiak Biosciences and its $83M IPO

Oct 14, 2020 10:26am
South Korea capital

South Korean exosome biotech Ilias Biologics nabs $20M B round

Sep 28, 2020 8:40am
Redbrick building with Sarepta name and logo

Sarepta taps Codiak's exosome tech in $72.5M neuromuscular deal

Jun 23, 2020 10:00am